Institutional & Family Asset Management »

Protagonist Therapeutics shares owned by Institutional & Family Asset Management

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Institutional & Family Asset Management from 13F filings

Historical chart of Institutional & Family Asset Management investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Institutional & Family Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Institutional & Family Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $463 16 28.94

More positions owned by Institutional & Family Asset Management

Ishares Tr Core Msci Eafe (IEFA)
Listed Fd Tr Core Alt Fd (CCOR)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Whitehall Fds High Div Yld (VYM)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p500 Etf (IVV)
Exxon Mobil Corporation (XOM)
Vanguard Index Fds Small Cp Etf (VB)
Ishares Tr U.s. Real Es Etf (IYR)
Plains All Amern Pipeline L Unit Ltd Partn (PAA)
Apple (AAPL)
Microsoft Corporation (MSFT)
JPMorgan Chase & Co. (JPM)
Ishares Tr Iboxx Inv Cp Etf (LQD)

View all positions for Institutional & Family Asset Management

Top funds holding Protagonist Therapeutics

Farallon Capital Management
BlackRock
BVF
Vanguard Group
Johnson & Johnson
Adage Capital Partners GP
Morgan Stanley
Cowen And Company
Geode Capital Management
Point72 Asset Management
Leucadia National Corporation
Kynam Capital Management
Perceptive Advisors
Marshall Wace
Fairmount Funds Management

View all funds holding Protagonist Therapeutics